NAD metabolism modulates inflammation and mitochondria function in diabetic kidney diseaseKomuraiah Myakala, Moshe Levi, Nataliia V. Shults et al.|Journal of Biological Chemistry|2023Cited by 71
EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse modelsAbhilash Venugopalan, Udayan Guha|Oncotarget|2016Cited by 50
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Udayan Guha|Molecular Case Studies|2016Cited by 24
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib ResistanceTapan K. Maity, Udayan Guha|Cancers|2023Cited by 9
Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879VXu Zhang, Udayan Guha|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 2